Data Protections Once Again Prevent Médunik From Launching Pediatric Drug

The Federal Court disagreed with Health Canada's interpretation of data protection regulations, once again reversing approval of pediatric drug RUZURGI.

READ MORE →

Stay informed. Subscribe to PCK IP’s insights for our latest commentary and updates.